{"schema_version":"secwatch.filing_event.v1","accession":"0001071739-22-000017","form_type":"8-K","ticker":"CNC","cik":"0001071739","company_name":"CENTENE CORP","filed_at":"2022-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.337847+00:00","generated_at":"2026-06-27T18:50:16.052182+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Centene appoints Leslie Norwalk to board under Politan Capital cooperation agreement","bullets":["Leslie Norwalk, former CMS Administrator and ex-Magellan Health director, elected to Centene's Board as Class II director.","Appointment fulfills cooperation agreement with Politan Capital Management LP, announced Dec. 14, 2021.","Norwalk will serve on Compliance, Environmental/Social Responsibility, and Government & Regulatory Affairs committees.","She brings expertise in government healthcare policy and biotech industry, per CEO Neidorff."],"urls":{"canonical":"https://secwatch.observer/filing/0001071739-22-000017","json":"https://secwatch.observer/filing/0001071739-22-000017.json","markdown":"https://secwatch.observer/filing/0001071739-22-000017.md","text":"https://secwatch.observer/filing/0001071739-22-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000017/0001071739-22-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000017/cnc-20220111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T18:50:16.052182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7ee0408aca","claim":"Leslie Norwalk was elected as Director at CENTENE CORP.","evidence_excerpt":"On January 11, 2022, the board of directors of the Company (the “Board”) elected Ms. Norwalk to the Board as a Class II director, with a term expiring at the Company’s 2024 annual meeting of stockholders, and appointed her to the Board’s Compliance Committee, Environmental and Social Responsibility Committee and Government and Regulatory Affairs Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000017/0001071739-22-000017-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}